Uhh no. The biggest problem with drug research is the ridiculously high amount of initial capital it takes to develop a drug. You can't just throw out buzzwords like "startups" and "software" like they're a panacea.
There isn't actually a single company that has succeeded in bringing drug development under millions of dollars in that list. The closest is the last one, but that company hasn't actually produced any results yet.
http://www.newsobserver.com/2010/04/14/436028/drug-startup-a...
http://www.facebook.com/group.php?gid=2355897150
http://industry.bnet.com/pharma/10006932/biotech-start-up-fl...